Psilocybin necklace | sterling silver Psilocybin is the molecule that has spent the last decade quietly returning to clinical research after a sixty-year regulatory pause. The 5-HT2A agonist behind psychedelic mushrooms, now in late-stage trials for treatment-resistant depression, end-of-life anxiety, and tobacco dependence. Worn here as a 30 mm sterling silver pendant. The Science Behind Psilocybin Albert Hofmann, the chemist who synthesised LSD in 1943, first isolated psilocybin and psilocin from Psilocybe mexicana in 1958. Psilocybin is a prodrug. Alkaline phosphatases remove the phosphate group within minutes of ingestion to produce psilocin, the active compound. Psilocin is structurally similar to serotonin: a tryptamine with a hydroxyl group at the 4-position that gives high-affinity binding at 5-HT2A receptors. Activation of 5-HT2A in the prefrontal cortex disrupts the default mode network, the resting-state network associated with self-referential thought. Clinical trials at Johns Hopkins, NYU, and Imperial College London have shown significant effects in treatment-resistant depression, end-of-life anxiety, and tobacco dependence. The FDA granted Breakthrough Therapy designation for depression in 2018. Who Reaches For This neuroscientists studying serotonin, consciousness, or the default mode network psychiatrists and clinical psychologists working in psychedelic medicine pharmacologists and psychopharmacology researchers anyone with a serious interest in the neuroscience of consciousness For the researcher or clinician who was interested in this molecule before it became clinically fashionable. Explore Related Molecules Jewelry Serotonin necklace | silver Fluoxetine necklace | silver THC necklace | silver THC necklace | gold vermeil Dopamine-serotonin earrings | silver FAQ Is this a recreational gift or a research gift? Almost always a research gift in practice. People who buy the psilocybin pendant tend to work somewhere along the psychedelic-medicine pipeline: neuroscience labs studying 5-HT2A receptors, psychiatry departments running clinical trials, pharmacology teams working on related tryptamines, or psychotherapists trained for psilocybin-assisted therapy protocols. The recreational reading exists, but it is the smaller share of the audience. Why is psilocybin in clinical trials now after sixty years of nothing? Because the early hostile regulatory environment ended and the basic-science case for the molecule was strong enough to bring it back. Psilocybin sits at the intersection of three things people in psychiatry have wanted to understand better for decades: the 5-HT2A receptor, the default mode network, and the persistent positive effects some patients report from a single dosing session. The clinical trials are testing whether those effects translate into reproducible, FDA-approvable treatments for conditions that conventional antidepressants have not solved. What size is the pendant and what is the return policy? 925 sterling silver, 30 mm pendant on a 45 cm sterling silver chain with a 5 cm extender. Nickel-free and hypoallergenic. Free worldwide DHL Express in 1-5 business days, with all import duties and taxes covered. 30-day “Love It or Return It” returns. Is there a gold version of psilocybin? Not at present. The psilocybin pendant is sterling silver only. Other psychedelic and psychiatric-medicine molecules in the catalogue (THC, fluoxetine, the dopamine-serotonin earring set) cover the same broader theme. THC and several adjacent neurotransmitters exist in both materials.
Related
Related
Related
Related